Opus Genetics (IRD) Earnings Analysis
Opus Genetics (IRD) next reports earnings on 2026-08-12, consensus EPS -0.15 USD. Last quarter (2026-05-21) it missed with EPS -0.19 USD vs -0.16 USD est (-18.8%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E -2.33.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does IRD next report earnings?
| Next earnings date | 2026-08-12 |
|---|---|
| Consensus EPS estimate | -0.15 USD |
| Revenue estimate | 0.00B |
IRD earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-21 | -0.19 USD | -0.16 USD | -18.8% | Miss |
| 2025-08-13 | -0.12 USD | -0.25 USD | +52% | Beat |
| 2025-05-15 | -0.32 USD | -0.34 USD | +5.9% | Beat |
| 2025-03-31 | -1.27 USD | -0.34 USD | -273.5% | Miss |
Beat rate: 2/4 (50%) over reported quarters with consensus data.
IRD valuation and analyst view
| Trailing P/E | -2.33 |
|---|---|
| Trailing EPS | -0.12306 USD |
| Price / book | -57.82 |
| Dividend yield | 0.00% |
| Market cap | 0.25B |
| Analyst consensus | Buy (7 buy / 0 hold / 0 sell) |
| Avg price target | 9.33 USD |
Related research pages
Frequently asked questions
When is Opus Genetics (IRD)'s next earnings date?
Opus Genetics is next scheduled to report on 2026-08-12, with a consensus EPS estimate of -0.15 USD and revenue estimate of 0.00B.
Did IRD beat earnings last quarter?
In its 2026-05-21 report, IRD posted EPS of -0.19 USD versus a -0.16 USD estimate — a miss of 18.8%.
What is IRD's earnings track record?
Over the last 4 reported quarters with consensus data, IRD beat estimates 2 times (50%).
What is IRD's current P/E ratio and EPS?
IRD trades at a trailing P/E of -2.33 on trailing EPS of -0.12306403058384913 USD.
What do analysts rate IRD?
Analyst consensus is "Buy" across 7 ratings (0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 9.33 USD.